-
BOC/BOA 2024 | Dr. Zhitao Ying: Annual Advances in Chinese Clinical Oncology 2023 ——Lymphoma)
Since 2015, the Chinese Society of Clinical Oncology (CSCO) has been dedicated to presenting annual reports on the progress of clinical oncology in China, under the theme “International Standards, Chinese Characteristics, Learning and Innovation.” At the recent “2024 Annual Progress in Chinese Clinical Oncology Conference (BOC) and Best of ASCO 2024 China,” the latest “Annual…
-
Dr. Huiqiang Huang: Advances in Clinical Immunotherapy for Lymphoma, Highlighting PD-1/PD-L1 Antibody Combination Therapies
In the realm of immunotherapy for lymphoma, PD-1/PD-L1 antibody combination therapies have emerged as a prominent area of research due to their precise modulation of the immune response. These therapies hold immense potential for enhancing efficacy and ensuring safety, providing lymphoma patients with more treatment options and the possibility of improved quality of life and…
-
Dr. Zhangyin Ming: TGF-β1 Released by Platelets Promotes Tumor Cell Autophagy, Mediates Epithelial-Mesenchymal Transition, and Tumor Metastasis
From June 22 to June 26, 2024, the 32nd International Society on Thrombosis and Haemostasis (ISTH 2024) conference was successfully held in Bangkok, Thailand. At this year’s conference, a study by Dr. Zhangyin Ming’s team from the School of Basic Medicine, Tongji Hospital of Huazhong University of Science and Technology, explored “The Role of Platelets…
-
EHA Expert Interview | Dr. Sizhou Feng: Insights from Resistant Bacterial Colonization in Hematology Patients for Empirical Therapy
Patients undergoing hematopoietic stem cell transplantation and high-dose chemotherapy for hematological diseases have impaired immune function, making them highly susceptible to febrile neutropenia and colonization or infection with resistant bacteria. Prompt and accurate initiation of empirical therapy is crucial to improve patient outcomes. At the 2024 European Hematology Association (EHA) Annual Meeting, Dr. Sizhou Feng’s…
-
Epigenetic Changes and Chromatin Architecture in Lipid Metabolic Reprogramming During Trastuzumab Adaptation in HER2-Positive Breast Cancer
In a significant advancement in breast cancer research, Dr. Yongmei Yin and her team from The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital published the article “Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2-Positive Breast Cancer” in Advanced Science on…
-
Dr. Zefei Jiang：Neoadjuvant-Adjuvant Pertuzumab in HER2-Positive Early Breast Cancer: Final Analysis of the Randomized Phase III PEONY Trial
Dr. Zefei Jiang from The Fifth Medical Center of Chinese PLA General Hospital, along with his colleagues, published the groundbreaking article titled “Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial” in Nature Communications on March 9, 2024. This pivotal research examines the long-term efficacy and safety of…
-
Dr. Xiaoyu Zhu and Dr. Aijie Huang on the Efficacy and Safety of TPO Receptor Agonists for Treating Thrombocytopenia Post-Cord Blood Transplantation 2
At the 32nd International Society on Thrombosis and Haemostasis (ISTH 2024) conference, the research team led by Professor Xiaoyu Zhu and Dr. Aijie Huang from The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital) garnered significant attention. Their study on the efficacy and safety of avatrombopag for treating…
-
BOC/BOA 2024 | Professor Shaohua Zhang: Treatment Strategies for Breast Cancer Patients Post-CDK4/6 Inhibitor Therapy
The results of studies such as postMONARCH and Young-PEARL presented at the 2024 ASCO Annual Meeting have sparked a new round of discussions on treatment strategies for patients with HR+/HER2- advanced breast cancer. To gain deeper insights into the significance of these studies and their implications for clinical practice, Professor Shaohua Zhang from The Fifth…
Connecting Medical Expertise through Media